WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES
Saved in:
| Main Authors: | Natallia Maroz, Ashantice Higgins, John Harcha, Kelsey Marshall, Derek Jernigan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924002328 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN24-1000 OUTCOMES OF ATYPICAL HEMOLYTIC UREMIC SYNDROME
by: Narayan Prasad, et al.
Published: (2024-04-01) -
WCN24-882 PHENOTYPES OF PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME
by: Ekaterina Ivanova, et al.
Published: (2024-04-01) -
WCN24-1367 DECODING THE UNCOMMON AETIOLOGY OF AN ATYPICAL HEMOLYTIC UREMIC SYNDROME CASE
by: Marina Leiva, et al.
Published: (2024-04-01) -
WCN24-1780 A TEN-YEAR EXPERIENCE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: A MONOCENTRIC PROSPECTIVE EXPERIENCE
by: Mariana Ursino, et al.
Published: (2024-04-01) -
Difficulties in diagnosing atypical hemolytic uremic syndrome
by: N. V. Fomina, et al.
Published: (2020-01-01)